{"id":836,"date":"2019-01-12T17:48:37","date_gmt":"2019-01-12T16:48:37","guid":{"rendered":"https:\/\/www.philix.be\/blog\/?p=836"},"modified":"2021-04-03T12:08:59","modified_gmt":"2021-04-03T10:08:59","slug":"anticorps-du-cgrp-cluster-headache","status":"publish","type":"post","link":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/","title":{"rendered":"Anticorps du CGRP pour traiter le Cluster Headache"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbsection\u00a0\u00bb _builder_version=\u00a0\u00bb3.22&Prime;][et_pb_row admin_label=\u00a0\u00bbrow\u00a0\u00bb _builder_version=\u00a0\u00bb3.25&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb3.25&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.9.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb hover_enabled=\u00a0\u00bb0&Prime; sticky_enabled=\u00a0\u00bb0&Prime;]<\/p>\n<p>Cet article a \u00e9t\u00e9 d\u00e9plac\u00e9 sur le site de <a href=\"https:\/\/ouch-belgium.be\/fr\/algie-vasculaire-de-la-face\/les-traitements-de-lalgie-vasculaire-de-la-face\/anticorps-du-cgrp\/definitions-anticorps-et-cgrp\/\">OUCH Belgium<\/a>, association de patients souffrants de Cluster Headache ou Algie Vasculaire de la Face<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cet article a \u00e9t\u00e9 d\u00e9plac\u00e9 sur le site de OUCH Belgium, association de patients souffrants de Cluster Headache ou Algie Vasculaire de la Face<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"Commen\u00e7ons par y mettre un peu de fran\u00e7ais :\r\n\r\nCGRP =\u00a0<strong>C<\/strong>alcitonin <strong>G<\/strong>ene-<strong>R<\/strong>elated <strong>P<\/strong>eptide => PRGC =\u00a0<strong>P<\/strong>eptide <strong>R<\/strong>eli\u00e9 au <strong>G<\/strong>\u00e8ne <strong>C<\/strong>alcitonine\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0\u00a0Et tu crois que \u00e7a va aider \u00e7a, gamin ? !<\/em>\r\n<em>\u2014\u00a0\u00a0Silence Raoul !<\/em><\/p>\r\nNous avons donc :\u00a0<strong>Anticorps<\/strong> du\u00a0<strong>peptide<\/strong> reli\u00e9 au <strong>g\u00e8ne<\/strong> <strong>calcitonine<\/strong>.\r\nEt nous voil\u00e0 avec quatre mots sur sept \u00e0 expliquer pour \u00eatre compris.\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 ... avant de commencer les explications, lol !<\/em>\r\n<em>\u2014\u00a0\u00a0Silence Raoul !<\/em><\/p>\r\n\r\n\r\n<hr \/>\r\n\r\n<strong>Anticorps<\/strong> :\r\n\r\n[caption id=\"attachment_842\" align=\"alignright\" width=\"213\"]<img class=\"wp-image-842 size-full\" src=\"https:\/\/www.philix.be\/blog\/wp-content\/uploads\/sites\/2\/2019\/01\/anticorps.gif\" alt=\"anticorps\" width=\"213\" height=\"198\" \/> <span style=\"font-size: 10pt; font-family: arial, helvetica, sans-serif;\"><em>Les anticorps neutralisent les antig\u00e8nes (en rouge) et les emp\u00eachent d'atteindre les r\u00e9cepteurs de la cellule (en bleu)<\/em><\/span>[\/caption]\r\n\r\nSubstance d\u00e9fensive fabriqu\u00e9e par l'organisme en pr\u00e9sence d'un antig\u00e8ne dont elle neutralise l'effet toxique.\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 ... MDR ! Tu as d\u00e9j\u00e0 perdu des lecteurs, lol !<\/em>\r\n<em>\u2014\u00a0\u00a0Si tu m'interromps sans arr\u00eat, \u00e7a ne va pas aider, hein !<\/em><\/p>\r\nBon, pour faire simple, disons qu'il s'agit d'une substance dans notre organisme\u00a0(soldat ami) qui va \"lutter\" contre une autre substance dans notre organisme (soldat ennemi). Ils peuvent le faire soit en les neutralisant, soit en bloquant leurs r\u00e9cepteurs.\r\nAinsi, l'<strong>anticorps<\/strong> du\u00a0<strong>peptide<\/strong> <strong>reli\u00e9 au<\/strong> <strong>g\u00e8ne<\/strong> <strong>calcitonine<\/strong>\u00a0va lutter contre ce peptide.\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 Aah, un peu comme un antivirus qui s'attaque \u00e0 un virus ?<\/em>\r\n<em>\u2014\u00a0 Pas tout \u00e0 fait mais c'est l'id\u00e9e ! Je vois que tu suis Raoul !<\/em>\r\n<em>\u2014\u00a0 ... reste \"<strong>peptide<\/strong> reli\u00e9 au <strong>g\u00e8ne<\/strong> <strong>calcitonine<\/strong>\" ! C'est quoi ce charabia ?<\/em>\r\n<em>\u2014\u00a0 J'y viens, j'y viens ...<\/em><\/p>\r\n\r\n\r\n<hr \/>\r\n\r\n<strong>Peptide<\/strong> :\r\n\r\nUn peptide est un <strong>polym\u00e8re<\/strong> d\u2019<strong>acides amin\u00e9s<\/strong> reli\u00e9s entre eux par des <a href=\"https:\/\/fr.wikipedia.org\/wiki\/Liaison_peptidique\"><strong>liaisons peptidiques<\/strong><\/a>.\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 \"Le chat mange la souris\". \"La souris est mang\u00e9e par le chat\".<\/em>\r\n<em>\u2014\u00a0 Pardon Raoul ?\r\n\u2014\u00a0 Oh, rien \u00e0 voir, j'essaye juste de faire des phrases simples pour soulager le lecteur ...\r\n\u2014\u00a0 Pffff ... Je continue ...<\/em><\/p>\r\n<p style=\"padding-left: 30px;\"><em>\u00a0<\/em><\/p>\r\n<strong>Polym\u00e8re<\/strong> :\r\n\r\n[caption id=\"attachment_851\" align=\"alignright\" width=\"300\"]<img class=\"wp-image-851 size-medium\" src=\"https:\/\/www.philix.be\/blog\/wp-content\/uploads\/sites\/2\/2019\/01\/Fluorocarbon-300x164.png\" alt=\"Fluorocarbone \" width=\"300\" height=\"164\" \/> <em><span style=\"font-family: arial, helvetica, sans-serif; font-size: 10pt;\">Fluorocarbone : polym\u00e8re constitu\u00e9 de la r\u00e9p\u00e9tition du groupe Fluor-Carbone-Fluor. Utilis\u00e9 pour remplac\u00e9 le nylon comme fil de p\u00eache.<\/span><\/em>[\/caption]\r\n\r\nUn polym\u00e8re est une<span style=\"font-size: 0.875rem;\">\u00a0tr\u00e8s grosse mol\u00e9cule constitu\u00e9e de la <span style=\"text-decoration: underline;\">r\u00e9p\u00e9tition<\/span> de nombreuses sous-unit\u00e9s.\r\nDans notre monde moderne on en connait beaucoup : Les plastiques, les colles, les vinyls, les polyesters, les silicones, etc. <\/span>\r\n\r\n<span style=\"font-size: 0.875rem;\">Mais ceux qui nous int\u00e9ressent font partie des polym\u00e8res naturels, comme le bois, le caoutchouc, l'amidon, les hormones, les <a href=\"https:\/\/fr.wikipedia.org\/wiki\/Prot%C3%A9ine\">prot\u00e9ines<\/a>, les acides nucl\u00e9iques : ADN et ARN et, dans le cas pr\u00e9sent, les <strong>acides amin\u00e9s<\/strong>.<\/span>\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 ---Ok-Bon-Ok-Bon-Ok-Bon-Ok---\r\n\u2014\u00a0 ---Bien-Raoul-Bien-Raoul---\r\n<\/em><\/p>\r\n<strong>Acides amin\u00e9s<\/strong> :\r\n\r\n[caption id=\"attachment_853\" align=\"alignright\" width=\"300\"]<img class=\"size-medium wp-image-853\" src=\"https:\/\/www.philix.be\/blog\/wp-content\/uploads\/sites\/2\/2019\/01\/acide-amine-300x214.png\" alt=\"\" width=\"300\" height=\"214\" \/> <em><span style=\"font-family: arial, helvetica, sans-serif; font-size: 10pt;\">Chaque acide amin\u00e9 est constitu\u00e9 d'une fonction amine, d'une fonction acide et d'une cha\u00eene lat\u00e9rale (R) variable<\/span><\/em>[\/caption]\r\n\r\nLes acides amin\u00e9s sont des mol\u00e9cules qui entrent dans la composition des <a href=\"https:\/\/fr.wikipedia.org\/wiki\/Prot%C3%A9ine\">prot\u00e9ines<\/a>.\r\nLeur nom provient du fait qu'ils poss\u00e8dent une fonction amine (NH2),\u00a0et une fonction acide carboxylique (COOH). Ils se distinguent par leur cha\u00eene lat\u00e9rale, R, qui peut \u00eatre un simple atome d'hydrog\u00e8ne (la glycine), ou \u00eatre bien plus complexe.\r\n\r\nIl existe une centaine d'acides amin\u00e9s, mais seuls 22 sont cod\u00e9s par le g\u00e9nome des organismes vivants.\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 L\u00e0 on a perdu des lecteurs, c'est s\u00fbr !\r\n\u2014\u00a0 Non Raoul, tu vas voir qu'\u00e0 la d\u00e9finition \"regroup\u00e9e\" suivante, \u00e7a devient compr\u00e9hensible.\r\n<\/em><\/p>\r\n<strong>Peptide = Polym\u00e8re<\/strong> d\u2019<strong>acides amin\u00e9s<\/strong> :\r\n\r\nUn peptide est donc une grosse mol\u00e9cule <span style=\"font-size: 0.875rem;\">constitu\u00e9e d'une cha\u00eene de plusieurs acides amin\u00e9s<\/span>.\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 Tu es s\u00fbr qu'on a encore des lecteurs ?\r\n\u2014\u00a0 Maiiiis oui ! T'inqui\u00e8te !\r\n<\/em><\/p>\r\nLes peptides\u00a0comportant deux acides amin\u00e9s (comme l'aspartame) sont nomm\u00e9s dipeptides. Ceux comportant trois acides amin\u00e9s sont nomm\u00e9s tripeptides. G\u00e9n\u00e9ralement, lorsqu\u2019ils sont plus longs, on parle simplement de peptides.\r\n\r\nLes polym\u00e8res comprenant un tr\u00e8s grand nombre d\u2019acides amin\u00e9s sont nomm\u00e9s polypeptides.\r\n\r\nEnfin, et l\u00e0 \u00e7a nous concerne,\u00a0<strong>un neuropeptide est un peptide fabriqu\u00e9 par un neurone<\/strong>\u00a0et le CGRP est un neuropeptide.\r\n\r\n<hr \/>\r\n\r\n<strong>Calcitonine<\/strong> :\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0 Allez ! la derni\u00e8re pour la route !<\/em><\/p>\r\nLa calcitonine est une hormone cod\u00e9e par un g\u00e8ne\u00a0situ\u00e9 sur le chromosome 11 humain.\r\nEt ce g\u00e8ne code aussi le\u00a0PRGC =\u00a0<strong>P<\/strong>eptide <strong>R<\/strong>eli\u00e9 au <strong>G<\/strong>\u00e8ne <strong>C<\/strong>alcitonine ou CGRP.\r\n<p style=\"padding-left: 30px;\">\u2014\u00a0 <em>D'o\u00f9 son nom un peu compliqu\u00e9 !\r\n\u2014\u00a0 Tu as tout compris, Raoul !<\/em><\/p>\r\n\r\n\r\n<hr \/>\r\n\r\n<strong>Le CGRP, oui mais\u00a0o\u00f9\u00a0<\/strong>:\r\n\r\n[caption id=\"attachment_856\" align=\"alignright\" width=\"121\"]<img class=\" wp-image-856\" src=\"https:\/\/www.philix.be\/blog\/wp-content\/uploads\/sites\/2\/2019\/01\/ganglion-trijumeau.gif\" alt=\"ganglion-trijumeau\" width=\"121\" height=\"115\" \/> <em><span style=\"font-family: arial, helvetica, sans-serif; font-size: 10pt;\">Ganglion trig\u00e9minal not\u00e9 \"G\"<\/span><\/em>[\/caption]\r\n\r\nLe CGRP est produit dans les neurones p\u00e9riph\u00e9riques et centraux et, pour ces derniers, ceux qui nous int\u00e9ressent sont situ\u00e9s dans le syst\u00e8me vasculaire trig\u00e9minal, o\u00f9 les corps cellulaires du ganglion trig\u00e9minal sont la principale source du CGRP.\r\n<p style=\"padding-left: 30px;\">\u2014\u00a0 <em>Donc le CGRP, c'est une esp\u00e8ce de truc pondu par des neurones \u00e0 la demande d'un g\u00e8ne du chromosome 11 !<\/em>\r\n<em>\u2014\u00a0 Bravo Raoul !\r\n\u2014\u00a0 D\u00e9cid\u00e9ment, l\u00e0 o\u00f9 il y a du g\u00e8ne, y'a pas d'plaisir ...\r\n\u2014\u00a0 Dans le cas pr\u00e9sent, pas vraiment, effectivement ...\r\n<\/em><\/p>\r\n\r\n\r\n<hr \/>\r\n\r\n<h3>Pourquoi un anticorps du CGRP pour traiter le <a href=\"https:\/\/www.ouch-belgium\/avf\">Cluster Headache<\/a> ?<\/h3>\r\n<em>\u2014\u00a0 Aah, fini les d\u00e9finitions, on attaque les explications !\r\n\u2014\u00a0 Oui Raoul, on y est !\r\n<\/em>\r\n\r\n<strong>Constat num\u00e9ro 1<\/strong>\r\n\r\nLors de crises de Cluster Headache ou Algie Vasculaire de la Face (AVF) provoqu\u00e9e par administration de nitroglyc\u00e9rine, on a mesur\u00e9 une augmentation sensible du taux de CGRP dans le plasma sanguin.\r\nSource :\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7540279\">Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.<\/a>\r\n\r\n<strong>Constat num\u00e9ro 2<\/strong>\r\n\r\nLorsqu'on administre du CGRP \u00e0 des patients souffrant de\u00a0Cluster Headache ou Algie Vasculaire de la Face (AVF) on provoque des attaques chez les patients \u00e9pisodiques en phase active et (un peu moins) chez les patients chroniques mais pas chez les patients \u00e9pisodiques en phase de r\u00e9mission.\r\nSource :\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29987329\">Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.<\/a>\r\n\r\n<strong>Hypoth\u00e8se et \u00e9tudes en cours<\/strong>\r\n\r\nEt si le CGRP \u00e9tait \u00e0 l'origine des crises de Cluster Headache ?\r\n\r\nIl suffirait alors de fabriquer un anticorps du CGRP pour bloquer l'action de celui-ci et, enfin, lib\u00e9rer les patients de ces <a href=\"https:\/\/www.ouch-belgium.be\/pain\">douleurs atroces<\/a> !\r\nCe qu'on appelle les anticorps monoclonaux sont des produits de bio-ing\u00e9nierie con\u00e7us pour se combiner \u00e0 des cibles particuli\u00e8res dans le corps et modifier notre physiologie (la fa\u00e7on dont notre corps fonctionne). C\u2019est une nouvelle fa\u00e7on de traiter des maladies.\r\n\r\nDeux approches sont possibles :\r\nCibler l'antig\u00e8ne (on attaque le soldat ennemi) ou cibler son r\u00e9cepteur (on prend sa place).\r\n\r\nA ce jour nous avons quatre anticorps monoclonaux du CGRP ou de son r\u00e9cepteur en test phase 3 (migraine et\/ou Cluster Headache) :\r\n<ul>\r\n \t<li><strong>erenumab<\/strong> (injection sous-cutan\u00e9e) qui cible <span style=\"text-decoration: underline;\">le r\u00e9cepteur<\/span> du CGRP\u00a0(pour la migraine uniquement) :\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01723514?term=AMG334&rank=3\">Ascending Multiple-Doses of AMG 334 in Healthy Subjects and in Migraine Patients<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02542605?term=AMG334&rank=4\">To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03096834?term=AMG334&rank=5\">A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03499119?term=AMG334&rank=6\">AMG 334 20160172 Pediatric Migraine PK Study.<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02630459?term=AMG334&rank=7\">A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention<\/a><\/li>\r\n \t<li><strong>galcanezumab<\/strong> (injection sous-cutan\u00e9e) qui cible le CGRP (pour migraine et cluster headache) :\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02438826?term=LY2951742&rank=1\">A Study of LY2951742 in Participants With Chronic Cluster Headache<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02397473?term=LY2951742&rank=2\">A Study of LY2951742 in Participants With Episodic Cluster Headache<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02104765?term=LY2951742&rank=4\">A Study of LY2951742 in Healthy Japanese and Caucasian Participants<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01625988?term=LY2951742&rank=5\">A Study of LY2951742 in Participants With Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01337596?term=LY2951742&rank=6\">A Study of LY2951742 in Healthy Volunteers<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02959190?term=LY2951742&rank=7\">A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02959177?term=LY2951742&rank=8\">A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02797951?term=LY2951742&rank=9\">A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache<\/a><\/li>\r\n \t<li><strong>fremanezumab<\/strong> (injection sous-cutan\u00e9e) qui cible le (pour migraine et cluster headache) :\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03303105?term=TEV48125&rank=1\">Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03303092?term=TEV48125&rank=2\">Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03303079?term=TEV48125&rank=3\">Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02638103?term=TEV48125&rank=4\">Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02964338?term=TEV48125&rank=5\">A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)<\/a> (Etude abandonn\u00e9e. Cause avanc\u00e9e par le laboratoire : le crit\u00e8re principal (changement du nombre moyen mensuel de crises de Cluster Headache pendant les 12 semaines de traitement) ne sera probablement pas atteint)\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02945046?term=TEV48125&rank=6\">A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02629861?term=TEV48125&rank=7\">Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02621931?term=TEV48125&rank=9\">Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine<\/a>\r\n\u2013\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03107052?term=TEV48125&rank=10\">A Study to Explore the Long-Term Safety of TEV-48125 (Fremanezumab) for the Prevention of Cluster Headache<\/a><\/li>\r\n \t<li><strong>eptinezumab<\/strong> (perfusion) qui cible le CGRP (pour la migraine uniquement) :\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02275117?term=ALD403&rank=3\">A Multicenter Assessment of ALD403 in Chronic Migraine<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01579383?term=ALD403&rank=4\">Safety Tolerability and Pharmacokinetics of ALD403<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02974153?term=ALD403&rank=5\">Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine<\/a>\r\n\u2013\u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02559895?term=ALD403&rank=6\">A Multicenter Assessment of ALD403 in Frequent Episodic Migraine<\/a><\/li>\r\n<\/ul>\r\nUn des avantages des anticorps monoclonaux inhibiteurs du CGRP est leur bonne tol\u00e9rabilit\u00e9.\r\nLes effets secondaires sont principalement reli\u00e9s \u00e0 la douleur au point d\u2019injection.\r\nOn oublie donc les effets secondaires courants comme un gain de poids, de la somnolence ou des difficult\u00e9s cognitives ou probl\u00e8mes cardiovasculaires. Aucun de ces effets n\u2019a \u00e9t\u00e9 signal\u00e9 avec les anticorps monoclonaux du CGRP.\r\n\r\n<hr \/>\r\n\r\n<div style=\"margin-bottom: 30px; padding: 15px; border: 2px solid red; box-shadow: -1px 2px 5px 1px rgba(0, 0, 0, 0.7),-1px 2px 20px rgba(255, 255, 255, 0.6) inset;\">\r\n\r\n<strong>Remarque importante :<\/strong>\r\n\r\nDans les \u00e9tudes ci-dessus, parmi celles concernant les patients souffrant de Cluster Headache, certaines sont termin\u00e9es <strong>mais aucune n'a encore de r\u00e9sultats d\u00e9finitifs publi\u00e9s<\/strong>.\r\nSeuls des articles faisant \u00e9tats de r\u00e9sultats <strong>interm\u00e9diaires<\/strong> existent !\r\nIls <strong>semblent<\/strong> encourageant pour les Cluster Headaches \u00e9pisodiques mais peu encourageant pour les Cluster Headache chroniques.\r\n\r\nA suivre ...\r\n\r\n<\/div>\r\n<p style=\"padding-left: 30px;\"><em>\u2014\u00a0\u00a0Merci m'sieur !<\/em>\r\n<em>\u2014\u00a0 De rien Raoul ! A bient\u00f4t !<\/em><\/p>","_et_gb_content_width":"","footnotes":""},"categories":[80],"tags":[],"class_list":["post-836","post","type-post","status-publish","format-standard","hentry","category-sante-fr","et-doesnt-have-format-content","et_post_format-et-post-format-standard"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anticorps du CGRP pour traiter le Cluster Headache - Blog &amp; Roll<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anticorps du CGRP pour traiter le Cluster Headache - Blog &amp; Roll\" \/>\n<meta property=\"og:description\" content=\"Cet article a \u00e9t\u00e9 d\u00e9plac\u00e9 sur le site de OUCH Belgium, association de patients souffrants de Cluster Headache ou Algie Vasculaire de la Face\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog &amp; Roll\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-12T16:48:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-03T10:08:59+00:00\" \/>\n<meta name=\"author\" content=\"Plerix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Plerix\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/\"},\"author\":{\"name\":\"Plerix\",\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/#\\\/schema\\\/person\\\/ec5965a7f3bb188abf819e2307bdfe36\"},\"headline\":\"Anticorps du CGRP pour traiter le Cluster Headache\",\"datePublished\":\"2019-01-12T16:48:37+00:00\",\"dateModified\":\"2021-04-03T10:08:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/\"},\"wordCount\":96,\"articleSection\":[\"Sant\u00e9\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/\",\"url\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/\",\"name\":\"Anticorps du CGRP pour traiter le Cluster Headache - Blog &amp; Roll\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/#website\"},\"datePublished\":\"2019-01-12T16:48:37+00:00\",\"dateModified\":\"2021-04-03T10:08:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/#\\\/schema\\\/person\\\/ec5965a7f3bb188abf819e2307bdfe36\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/2019\\\/01\\\/12\\\/anticorps-du-cgrp-cluster-headache\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anticorps du CGRP pour traiter le Cluster Headache\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/\",\"name\":\"Blog &amp; Roll\",\"description\":\"Les sites de Ph\u00a1l\u00a1x\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/#\\\/schema\\\/person\\\/ec5965a7f3bb188abf819e2307bdfe36\",\"name\":\"Plerix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/337b900c7c6eef754f29620079e343986d20b0e04e47f4a8c13d74bf4fe6c357?s=96&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/337b900c7c6eef754f29620079e343986d20b0e04e47f4a8c13d74bf4fe6c357?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/337b900c7c6eef754f29620079e343986d20b0e04e47f4a8c13d74bf4fe6c357?s=96&r=g\",\"caption\":\"Plerix\"},\"sameAs\":[\"https:\\\/\\\/www.philix.be\"],\"url\":\"https:\\\/\\\/www.philix.be\\\/blog\\\/author\\\/plerix\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anticorps du CGRP pour traiter le Cluster Headache - Blog &amp; Roll","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/","og_locale":"fr_FR","og_type":"article","og_title":"Anticorps du CGRP pour traiter le Cluster Headache - Blog &amp; Roll","og_description":"Cet article a \u00e9t\u00e9 d\u00e9plac\u00e9 sur le site de OUCH Belgium, association de patients souffrants de Cluster Headache ou Algie Vasculaire de la Face","og_url":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/","og_site_name":"Blog &amp; Roll","article_published_time":"2019-01-12T16:48:37+00:00","article_modified_time":"2021-04-03T10:08:59+00:00","author":"Plerix","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Plerix"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/#article","isPartOf":{"@id":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/"},"author":{"name":"Plerix","@id":"https:\/\/www.philix.be\/blog\/#\/schema\/person\/ec5965a7f3bb188abf819e2307bdfe36"},"headline":"Anticorps du CGRP pour traiter le Cluster Headache","datePublished":"2019-01-12T16:48:37+00:00","dateModified":"2021-04-03T10:08:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/"},"wordCount":96,"articleSection":["Sant\u00e9"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/","url":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/","name":"Anticorps du CGRP pour traiter le Cluster Headache - Blog &amp; Roll","isPartOf":{"@id":"https:\/\/www.philix.be\/blog\/#website"},"datePublished":"2019-01-12T16:48:37+00:00","dateModified":"2021-04-03T10:08:59+00:00","author":{"@id":"https:\/\/www.philix.be\/blog\/#\/schema\/person\/ec5965a7f3bb188abf819e2307bdfe36"},"breadcrumb":{"@id":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.philix.be\/blog\/2019\/01\/12\/anticorps-du-cgrp-cluster-headache\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.philix.be\/blog\/"},{"@type":"ListItem","position":2,"name":"Anticorps du CGRP pour traiter le Cluster Headache"}]},{"@type":"WebSite","@id":"https:\/\/www.philix.be\/blog\/#website","url":"https:\/\/www.philix.be\/blog\/","name":"Blog &amp; Roll","description":"Les sites de Ph\u00a1l\u00a1x","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.philix.be\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.philix.be\/blog\/#\/schema\/person\/ec5965a7f3bb188abf819e2307bdfe36","name":"Plerix","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/337b900c7c6eef754f29620079e343986d20b0e04e47f4a8c13d74bf4fe6c357?s=96&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/337b900c7c6eef754f29620079e343986d20b0e04e47f4a8c13d74bf4fe6c357?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/337b900c7c6eef754f29620079e343986d20b0e04e47f4a8c13d74bf4fe6c357?s=96&r=g","caption":"Plerix"},"sameAs":["https:\/\/www.philix.be"],"url":"https:\/\/www.philix.be\/blog\/author\/plerix\/"}]}},"_links":{"self":[{"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/posts\/836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/comments?post=836"}],"version-history":[{"count":3,"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/posts\/836\/revisions"}],"predecessor-version":[{"id":1148,"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/posts\/836\/revisions\/1148"}],"wp:attachment":[{"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/media?parent=836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/categories?post=836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.philix.be\/blog\/wp-json\/wp\/v2\/tags?post=836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}